Search Login Register
Amelogenesis Imperfecta
Summary
Description:
A clinically and genetically heterogeneous group of hereditary conditions characterized by malformed DENTAL ENAMEL, usually involving DENTAL ENAMEL HYPOPLASIA and/or TOOTH HYPOMINERALIZATION.
Key Drugs and Agents for Amelogenesis Imperfecta
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Amelogenin
:
7 studies in 60 results
: IBA
-
tuftelin (enamelin)
:
5 studies in 26 results
: IBA
-
Proteins (Proteins, Gene)
:
1 study in 12 results
: IBA
-
Sodium Hypochlorite (Clorox)
:
1 study in 3 results
: IBA
-
Calcium Carbonate (Limestone)
:
1 study in 3 results
:
FDA 3
-
Codon (Codons)
:
1 study in 2 results
: IBA
-
Transcription Factors (Transcription Factor)
:
1 study in 1 result
: IBA
-
RNA (Ribonucleic Acid)
:
1 study in 1 result
: IBA
-
Ethylnitrosourea (N-Ethyl-N-nitrosourea)
:
1 study in 1 result
: IBA
-
Coloring Agents (Dyes)
:
1 study in 1 result
: IBA
Show All >>
Diseases Related to Amelogenesis Imperfecta
-
Mandibulofacial Dysostosis (Treacher Collins Syndrome)
-
Tooth Diseases
-
Stomatognathic Diseases (Dental Disease)
-
Craniosynostoses (Craniosynostosis)
-
Retinitis Pigmentosa (Pigmentary Retinopathy)
Show All >>
Key Therapies for Amelogenesis Imperfecta
Efficacy Chart >>
-
Crowns (Crown, Dental)
:
1 study in 9 results
-
Overlay Denture
:
1 study in 4 results
-
Prosthodontics
:
15 results
-
Mouth Rehabilitation
:
6 results
-
Orthodontics
:
3 results
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.